Apellis Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $32 From $40
Apellis Pharmaceuticals Inc:派傑投資將目標價從40美元調降至32美元
Apellis Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $32 From $40
Apellis Pharmaceuticals Inc:派傑投資將目標價從40美元調降至32美元
譯文內容由第三人軟體翻譯。